Source:http://linkedlifedata.com/resource/pubmed/id/19740552
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-4
|
pubmed:dateCreated |
2010-2-1
|
pubmed:abstractText |
Homeostasis in the intestinal microenvironment between the immune system and luminal antigens appears disturbed in chronic enteropathies. Pro-inflammatory cytokines likely play a role in the pathogenesis of intestinal inflammation. Several inflammatory and immunoregulatory genes have associated nuclear factor-kappaB (NF-kappaB) binding sites, which allow NF-kappaB to regulate gene transcription. The purpose of this study was to investigate (1) the occurrence of NF-kappaB activation during mucosal inflammation in situ, (2) the mucosal distribution pattern of cells expressing activated NF-kappaB within treatment groups, and (3) the effect of specific therapy on NF-kappaB activation. Dogs with chronic enteropathy were studied (n=26) and compared with 13 healthy dogs. Ten dogs had food responsive disease (FRD) and 16 had inflammatory bowel disease (IBD). NF-kappaB activation was detected in duodenal mucosal biopsies using a mouse monoclonal antibody (MAB 3026) that selectively binds the nuclear localization sequence of activated NF-kappaB. To identify macrophages, biopsies were stained using the MAC 387 antibody. Macrophages in the lamina propria double-stained for MAC 387 and NF-kappaB were quantitated; epithelial cell expression of activated NF-kappaB was determined semi-quantitatively. Results showed that more macrophages positive for activated NF-kappaB were present in lamina propria of dogs with chronic enteropathy compared to control dogs (p<0.01). More NF-kappaB positive epithelial cells were observed in FRD dogs compared to IBD dogs (p<0.05). After therapy, the number of macrophages and epithelial cells staining positive for activated NF-kappaB decreased (p<0.01) in chronic enteropathy dogs. In conclusion, activation of NF-kappaB is closely associated with the pathophysiology of canine chronic enteropathy. Down-regulation follows successful therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1873-2534
|
pubmed:author |
pubmed-author:AllenspachKarinK,
pubmed-author:BurgenerIwan AIA,
pubmed-author:DobbelaereDirkD,
pubmed-author:ForsterUrsulaU,
pubmed-author:GaschenFrédéricF,
pubmed-author:HallJean AJA,
pubmed-author:HermannPascalP,
pubmed-author:LuckschanderNicoleN,
pubmed-author:WelleMonikaM,
pubmed-author:WenzlowNannyN
|
pubmed:copyrightInfo |
Published by Elsevier B.V.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
133
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
228-36
|
pubmed:meshHeading |
pubmed-meshheading:19740552-Animals,
pubmed-meshheading:19740552-Antibodies, Monoclonal,
pubmed-meshheading:19740552-Case-Control Studies,
pubmed-meshheading:19740552-Chronic Disease,
pubmed-meshheading:19740552-Dog Diseases,
pubmed-meshheading:19740552-Dogs,
pubmed-meshheading:19740552-Immunohistochemistry,
pubmed-meshheading:19740552-Inflammatory Bowel Diseases,
pubmed-meshheading:19740552-Intestinal Diseases,
pubmed-meshheading:19740552-Intestinal Mucosa,
pubmed-meshheading:19740552-Macrophages,
pubmed-meshheading:19740552-Mice,
pubmed-meshheading:19740552-NF-kappa B
|
pubmed:year |
2010
|
pubmed:articleTitle |
Activation of nuclear factor-kappaB in dogs with chronic enteropathies.
|
pubmed:affiliation |
Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|